Literature DB >> 25115194

Survival rate of etanercept for psoriasis in real life: a multicentre observational study.

Enrique Herrera-Acosta1, Jorge A Suárez-Pérez1, José Aguilera2, Francisco Gómez-García3, Rafael Jiménez-Puya3, Francisco Guimerá4, Maria V Mendiola1, Enrique Herrera-Ceballos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25115194     DOI： 10.1684/ejd.2014.2400

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  1 in total

1.  Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Authors:  A Menter; K A Papp; M Gooderham; D M Pariser; M Augustin; F A Kerdel; S Fakharzadeh; K Goyal; S Calabro; W Langholff; S Chavers; D Naessens; J Sermon; G G Krueger
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-03-30       Impact factor: 6.166
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.